Reports

Placeholder

Global Non Invasive Prenatal Testing (NIPT) Market 2017 2023

SACIPKSP702802
Published Date: 10/15/2017
Number of Pages: 241
Single User License $2,795.00
Global Users License $4,795.00

Product Description

Description

The major NIPTs currently available in the global market are MaterniT21 PLUS Harmony Panorama verifi NIFTY PrenaTest IONA and BambniTest among others. Of these Panorama held the largest share of 19 of the market in terms of revenue in 2016 followed by NIFTY with 16. MaterniT21 PLUS gained the first mover advantage in the NIPT market as it was the first non invasive prenatal test launched in the market by Sequenom Inc. in October 2011. However IONA test is projected to be the fastest growing segment expanding at a CAGR of 24.4 during the forecast period from 2017 to 2023.

The global NIPT market has a high growth potential in future and will account to $XX billion by 2023 growing at a CAGR of XX from 2017 to 2023.

In terms of volume 1541100 NIPT tests were performed in 2016 and the number is anticipated to reach XX units by 2023. The NIPT market volume is growing at a CAGR of XX during the forecast period.

Table of Content

1 Executive Summary
2 Report Scope & Methodology
2.1 Scope of Report
2.2 Global NIPT Market Segmentation
2.3 Key Learnings
2.4 Research Methodology
2.4.1 Data Triangulation
2.4.2 Key Data Points from Secondary Sources
2.4.3 Key Data Points from Primary Sources
2.4.4 Top-Down Approach (Segment Analysis)
2.4.5 Bottom-Up-Approach (Segment Analysis)
2.4.6 Assumptions and Limitations
2.4.7 Data and Prediction Modelling
3 Market Overview
3.1 Introduction
3.2 Benefits and Risks of NIPT
3.3 Technological Approach for NIPT
3.4.1 Fetal Cell Maternal Blood (FCMB)
3.4.2 Cell-Free NIPT Test
3.5 Patent Landscape
3.6 World Economic Outlook of Prenatal Testing Market, 2016
4 Market Dynamics
4.1 Market Drivers
4.2 Market Challenges
4.3 Market Opportunities
5 Major Chromosomal Aneuploidies
6 Competitive Landscape
6.1 Key Developments & Strategies
6.2 Market Attractiveness Analysis: Global Non-Invasive Prenatal Testing Market, by Geography
6.3 Growth Share Matrix
6.4 Porter’s Five Forces Analysis
6.5 Value Chain Analysis
7 Global NIPT Market, By Test (Volume and Value)
7.1 Market Overview
7.2 Paranoma Test
7.3 Sequenom Test Test
7.4 Harmony Test
7.5 NIFTY Test
7.6 verifi Test
7.7 IONA Test
7.8 Prena Test
7.9 BambniTest
7.10 Other NIPT Tests
8 Global NIPT Market, By Test (Volume and Value)
8.1 Geographical Scenario
8.2 North America
8.3 Europe
8.4 Asia Pacific
8.4.1 Market Overview
8.4.2 Country Analysis
8.4.3 China
8.4.4 Japan
8.4.5 Australia
8.4.6 India
8.4.7 Singapore
8.4.8 Hong Kong
8.4.9 Malaysia
8.4.10 Indonesia
8.4.11 Vietnam
8.4.12 South Korea
8.4.13 Philippines
8.4.14 Thailand
8.5.5 RoW
9 End User Perception
10 Company Profiles
10.1 Laboratory Corporation of America
10.2 Roche AG
10.3 Premaitha Health Plc
10.4 Illumina Inc.
10.5 Natera Inc.
10.6 Quest Diagnostics
10.7 BGI Diagnostics
10.8 LifeCodexx AG
10.9 Berry Genomics
10.1 NIPD Genetics

Search Reports

Top